Columbia researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
Columbia researchers have used blockchain technology to build a system that can securely store, share, and analyze genetic and clinical data for precision medicine research.
A “loopy” discovery in bacteria is raising fundamental questions about the makeup of our own genome. And revealing a potential wellspring of material for new genetic therapies.
3-D organoids created from the bladder cancers of patients mimic the characteristics of each patient’s tumor and may be used in the future to identify the best treatment for each patient.
Columbia is helping to enroll 1 million Americans in “All of Us,” a large-scale effort to accelerate the medical research that will lead to individualized health care.
Two research teams at Columbia University Irving Medical Center have received grants from the Chan Zuckerberg Initiative to help build a Human Cell Atlas.
On Tuesday, learn more about the NIH's All of Us project, an effort to gather genetic and health data from 1 million Americans to accelerate research and improve health.
Researchers have found a way to identify disease-causing genetic mutations in the non-coding region of the genome, which has been uninterpretable until now.
New genetic findings should help researchers uncover how MacTel, a disease of the retina, develops and how to design therapies to prevent loss of vision.
Columbia and NewYork-Presbyterian research has shown that several genes implicated in rare forms of pediatric epilepsy also contribute to common forms of the disorder.
Columbia University researchers have created a user-friendly program that rapidly predicts which genes are implicated in an individual’s cancer and recommends treatments.